Overview

Ramucirumab for Advanced Pre-treated Biliary Cancers

Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if ramucirumab can help to control biliary cancer. The safety of this drug will also be studied.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
Eli Lilly and Company
Treatments:
Ramucirumab